Johnson and Johnson announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved Rybrevant (amivantamab-vmjw) in combination with chemotherapy (carboplatin-pemetrexed) for the first-line treatment of patients w
The current impediments to bilateral relations include tariff and non-tariff barriers, complex custom clearance procedures, IPR and data localization issues†- David Sanford Wolfe, Chairman, Aaron Capital, Inc USA.
The Indian active pharmaceutical ingredient (API) industry believes that the Make in India initiative and the PLI (production-linked incentive) scheme will help limit imports from China.
To revolutionize the healthcare landscape, the 8th Edition of CAHOCON 2024 is set to unfold between April 6 and 7 at the Biswa Bangla Convention Centre in Kolkata with a theme that resonates globally.
India has continued on toward turned into a significant exporter of bulk drugs and medical devices, Health Minister, Mansukh Mandaviya said. As per him, India dealt with plans and plans to de-risk its store network from worldwide ideas and...
Ginkgo Bioworks, a startup developing the leading platform for cell programming and biosecurity, has announced the purchase of key assets from Reverie Labs, which created and applied AI/ML techniques to expedite drug discovery. Ginkgo has...
Intelligent Bio Solutions Inc., a medical technology company delivering smart, rapid, non-invasive testing solutions, has announced its partnership with Cliantha Research, a full-service clinical research organization, to perform a pharmacokinetic
Stryker, a major player in the medical technology space, expanded its prototyping and testing facilities in India on Thursday. According to a press release, this move represents significant growth in our RandD landscape.
Indian contract drug manufacturer Suven Pharmaceuticals (SUVH.NS) opened a new tab and said it merged with Chance Lifesciences on Thursday in an all-share deal as it looks to scale up its contract and development manufacturing services
The Supreme Court has directed the Centre to discuss with states and develop a concrete plan for uniform and affordable healthcare services for citizens that will be on a par with the rates fixed by impaneled hospitals under the Central Government
, CDSCO.jpg)
.jpg)